Fine-Grained Forecasting of COVID-19 Trends at the County Level in the United States

The coronavirus (COVID-19) pandemic has profoundly impacted various aspects of daily life, society, healthcare systems, and global health policies. This pandemic has resulted in more than one hundred million people being infected and, unfortunately, the loss of life for many individuals. Although treatment for the coronavirus is now available, effective forecasting of COVID-19 infection is the most importance to aid public health officials in making critical decisions. However, forecasting COVID-19 trends through time-series analysis poses significant challenges due to the data’s inherently dynamic, transient, and noise-prone nature. In this study, we have developed the Fine-Grained Infection Forecast Network (FIGI-Net) model, which provides accurate forecasts of COVID-19 trends up to two weeks in advance. FIGI-Net addresses the current limitations in COVID-19 forecasting by leveraging fine-grained county-level data and a stacked bidirectional LSTM structure. We employ a pre-trained model to capture essential global infection patterns. Subsequently, these pre-trained parameters were transferred to train localized sub-models for county clusters exhibiting comparable infection dynamics. This model adeptly handles sudden changes and rapid fluctuations in data, frequently observed across various times and locations of county-level data, ultimately improving the accuracy of COVID-19 infection forecasting at the county, state, and national levels. FIGI-Net model demonstrated significant improvement over other deep learning-based models and state-of-the-art COVID-19 forecasting models, evident in various standard evaluation metrics. Notably, FIGI-Net model excels at forecasting the direction of infection trends, especially during the initial phases of different COVID-19 outbreak waves. Our study underscores the effectiveness and superiority of our time-series deep learning-based methods in addressing dynamic and sudden changes in infection numbers over short-term time periods. These capabilities facilitate efficient public health management and the early implementation of COVID-19 transmission prevention measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by NIH, United States (Grant Number: R35GM133725).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesCan you update the data availability statement and send me the pdf file? The data used in this study are publicly available and consist of daily COVID-19 cumulative infectious and death cases reported for U.S. counties. The dataset was obtained from the Johns Hopkins Center for Systems Science and Engineering (CSSE) Coronavirus Resource Center, spanning from January 21st, 2020, to April 16th, 2022 [14]. The dataset can be directly accessed from the Johns Hopkins CSSE Coronavirus Resource Center website (https://github.com/CSSEGISandData/COVID-19). Researchers interested in utilizing the data for further analysis can refer to the original source for detailed documentation on data collection methods and definitions. For additional information or inquiries about the dataset, please visit the website or contact the Johns Hopkins CSSE Coronavirus Resource Center.